The Venture Codex Logo

The Venture Codex

Claris Ventures

Piazza San Carlo 206, Torino, Piemonte, Italy

Overview

Venture capital firm investing in early-stage biopharma companies.

Founded

2019

Deals · 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A
Series B

Geographic focus

France
Italy
United Kingdom

Sector focus

—

Investment portfolio

10rounds
NAMEDATESIZE
Haptena Therapeutics
Dec 2025Led
$4 MSeed
Lever Bio
May 2025Led
$5 MOther Equity
NeoPhore
Feb 2024Participated
$12 MSeries B
Resalis Therapeutics
Jan 2024Participated
$11 MSeries A
Resalis Therapeutics
Feb 2023Led
$11 MSeed
NeoPhore
Jan 2023Participated
$7 MSeries B
Sibylla Biotech
Oct 2022Participated
$23 MSeries A
Kither Biotech
Mar 2022Led
$20 MSeries B
NeoPhore
Mar 2021Led
$21 MSeries B
YouScribe
Nov 2012Participated
$3 MOther Equity
Haptena Therapeutics
Dec 2025Led
$4 MSeed
Lever Bio
May 2025Led
$5 MOther Equity
NeoPhore
Feb 2024Participated
$12 MSeries B
Resalis Therapeutics
Jan 2024Participated
$11 MSeries A
Resalis Therapeutics
Feb 2023Led
$11 MSeed
NeoPhore
Jan 2023Participated
$7 MSeries B
Sibylla Biotech
Oct 2022Participated
$23 MSeries A
Kither Biotech
Mar 2022Led
$20 MSeries B
NeoPhore
Mar 2021Led
$21 MSeries B
YouScribe
Nov 2012Participated
$3 MOther Equity
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Claris Ventures: 10 funding rounds are recorded in the selected participation categories.All available history.
Claris Ventures: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed20
Series A02
Series B22
Other Equity11

Monthly Deal Activity

Claris Ventures: 10 deals are recorded across 168 months.All available history.
Claris Ventures: 10 deals are recorded across 168 months. All available history
MonthDeals
Nov '121
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '231
Feb '231
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '241
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Claris Ventures: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Claris Ventures: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Enterprise Software3
Professional Services3
Consumer & Lifestyle2
E-Commerce & Retail1
Social & Community Platforms1

Deal Size Distribution

Claris Ventures: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Claris Ventures: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M1
$10M-$25M6
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Claris Ventures: Europe has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Claris Ventures: Europe has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
Europe9
Italia1
Claris Ventures: 20 co-investors are shown, with 3B Future Health Fund sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Claris Ventures: 20 co-investors are shown, with 3B Future Health Fund sharing 5 recorded deals. All available history
Co-investorShared deals
3B Future Health Fund5
2Invest3
Astellas Venture Management3
CDP Venture Capital2
Club degli Investitori2
CRT Pioneer Fund2
Italian Angels for Growth2
2 Invest1
ACE Venture1
Alef 61
CPF1
Ersel1
Gilberte Beaux family1
Habert Dassault Finance1
Indaco Venture Partners1
Iris Capital1
LIFTT1
Neva SGR1
Seroba Life Sciences1
Simon Fiduciaria1

Investment Strategy

Claris Ventures: Led accounts for 50% and participating for 50% of round participation.All available history.
Claris Ventures: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led550%
Participating550%
Claris Ventures: Single-lead accounts for 80% and co-led for 20% of lead dynamics.All available history.
Claris Ventures: Single-lead accounts for 80% and co-led for 20% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead480%
Co-led120%

Team

Barbara Castellano

Investment committee member

Ciro Spedaliere

Partner

Lola Buono

Senior Associate

Pietro Puglisi

Founder